Skip to content

Advertisement

BMC Infectious Diseases

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study

  • Edward J. Gane1Email author,
  • Edwin DeJesus2,
  • Ewa Janczewska3,
  • Jacob George4,
  • Moises Diago5,
  • Mariliza Hendrique Da Silva6,
  • Henk Reesink7,
  • Igor Nikitin8,
  • Holger Hinrichsen9,
  • Stefan Bourgeois10,
  • Peter Ferenci11,
  • Umesh Shukla12,
  • Ronald Kalmeijer12,
  • Oliver Lenz13,
  • Bart Fevery13,
  • Chris Corbett13,
  • Maria Beumont13 and
  • Wolfgang Jessner13
BMC Infectious DiseasesBMC series – open, inclusive and trusted201717:389

https://doi.org/10.1186/s12879-017-2444-3

Received: 12 January 2017

Accepted: 7 May 2017

Published: 2 June 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
12 Jan 2017 Submitted Original manuscript
30 Jan 2017 Reviewed Reviewer Report - Marianne Martinello
5 Feb 2017 Reviewed Reviewer Report - Behzad Hajarizadeh
4 Apr 2017 Author responded Author comments - Edward J Gane
Resubmission - Version 2
4 Apr 2017 Submitted Manuscript version 2
4 May 2017 Author responded Author comments - Edward J Gane
Resubmission - Version 3
4 May 2017 Submitted Manuscript version 3
Publishing
7 May 2017 Editorially accepted
2 Jun 2017 Article published 10.1186/s12879-017-2444-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
New Zealand Liver Transplant Unit, Auckland City Hospital
(2)
Orlando Immunology Center
(3)
Outpatients Clinic for Hepatology, ID Clinic
(4)
Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney
(5)
Hospital Quiron De Valencia
(6)
Reference and Training Center IST/AIDS – State Program of São Paulo
(7)
Academic Medical Center
(8)
Institution of Russian Academy of Sciences Central Clinical Hospital
(9)
Leberstudienzentrum Kiel GbR
(10)
(11)
Allgemeines Krankenhaus der Stadt Wien, Universitätsklinik für Innere Medizin III
(12)
Janssen Research & Development, LLC
(13)
Janssen Pharmaceutica NV

Advertisement